Investigators identified urokinase-type plasminogen activator receptor (uPAR) as a potential therapeutic target for diffuse-type gastric cancer.
[Science Advances]
Home Newsletters Intestinal Cell News Therapeutic Strategies Targeting uPAR Potentiate anti–PD-1 Efficacy in Diffuse-Type Gastric Cancer
